Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth

被引:23
作者
Mizuguchi, H
Nakanishi, T
Nakanishi, M
Nakagawa, T
Nakagawa, S
Mayumi, T
机构
[1] OSAKA UNIV, FAC PHARMACEUT SCI, SUITA, OSAKA 565, JAPAN
[2] OSAKA UNIV, MICROBIAL DIS RES INST, SUITA, OSAKA 565, JAPAN
[3] RES DEV CORP JAPAN, PRESTO, KAWAGUCHI, SAITAMA 332, JAPAN
关键词
fusogenic liposome; Sendai virus; fragment A of diphtheria toxin; intratumor; Sarcoma-180;
D O I
10.1016/0304-3835(95)04081-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously, we reported that experimental i.p. administration of fusogenic liposomes containing fragment A of diphtheria toxin (DTA) completely regressed ascites tumors without ally severe side effects. In this study, we examined the therapeutic effects of intratumor injection of fusogenic liposomes using ddY mice implanted with Sarcoma-180 (S-180) cells intradermally. Intratumor injections of fusogenic liposomes containing DTA significantly inhibited the tumor growth as assessed by the relative mean tumor volume, and by the survival time of the mice. No therapeutic effects were observed when simple liposomes containing DTA or empty fusogenic liposomes were administered. Using [H-3]inulin encapsulated in fusogenic liposomes as a marker, we demonstrated that fusogenic liposomes delivered their contents into the solid tumor cells about 15 times more efficiently than simple liposomes. These results suggest that intratumor administration of fusogenic liposomes containing DTA is a highly effective approach to the local treatment of solid tumors.
引用
收藏
页码:63 / 69
页数:7
相关论文
共 21 条
[1]  
ASHER AL, 1991, J IMMUNOL, V146, P3227
[2]   INTRATUMOR TREATMENT OF C3H MOUSE MAMMARY-CARCINOMA WITH 5-FLUOROURACIL ADSORBED ON ACTIVATED-CHARCOAL PARTICLES [J].
BONHOMME, L ;
MATHIEU, MC ;
AMDIDOUCHE, D ;
FAURE, E ;
GUISTEAU, D ;
FREDJ, G ;
NAVEAU, S .
ANTI-CANCER DRUGS, 1992, 3 (03) :261-266
[3]  
CARROLL SF, 1988, METHOD ENZYMOL, V165, P218
[4]   AN EASIER, REPRODUCIBLE, AND MASS-PRODUCTION METHOD TO STUDY THE BLOOD-BRAIN-BARRIER INVITRO [J].
DEHOUCK, MP ;
MERESSE, S ;
DELORME, P ;
FRUCHART, JC ;
CECCHELLI, R .
JOURNAL OF NEUROCHEMISTRY, 1990, 54 (05) :1798-1801
[5]   VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J].
DRANOFF, G ;
JAFFEE, E ;
LAZENBY, A ;
GOLUMBEK, P ;
LEVITSKY, H ;
BROSE, K ;
JACKSON, V ;
HAMADA, H ;
PARDOLL, D ;
MULLIGAN, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3539-3543
[6]   TREATMENT OF ESTABLISHED RENAL-CANCER BY TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-4 [J].
GOLUMBEK, PT ;
LAZENBY, AJ ;
LEVITSKY, HI ;
JAFFEE, LM ;
KARASUYAMA, H ;
BAKER, M ;
PARDOLL, DM .
SCIENCE, 1991, 254 (5032) :713-716
[7]  
KATO K, 1991, J BIOL CHEM, V266, P22071
[8]  
KATO K, 1991, J BIOL CHEM, V266, P3361
[9]   CONJUGATES OF ANTICANCER AGENTS AND POLYMERS - ADVANTAGES OF MACROMOLECULAR THERAPEUTICS INVIVO [J].
MAEDA, H ;
SEYMOUR, LW ;
MIYAMOTO, Y .
BIOCONJUGATE CHEMISTRY, 1992, 3 (05) :351-362
[10]  
MIZUGUCHI H, IN PRESS BR J CANC